PROGRAMME KEYNOTES

 

Brian Clark

Brian
Clark

Ohio University
Athens, OH USA

Neuromuscular changes with aging and sarcopenia

Charlotte A.Peterson

Charlotte
A.Peterson

University of Kentucky
Lexington, KY USA

Muscle cell regenerative capacity and aging

Linda Fried

Linda
Fried

Columbia University
New York, NY USA

Frailty: What's been done and what needs doing

Cornell Sieber

Cornell
Sieber

F. Alexander-University
Nuremberg, Germany

Nutrition, sarcopenia and frailty

Nathan Lebrasseur

Nathan
Lebrasseur

Mayo Clinic
Rochester, NY USA

Myostatin and other biomarkers of sarcopenia

Joshua M Hare

Joshua M Hare

Longeveron, Miami, FL USA

Stems cells for frailty : rational, biological and clinical impact

SYMPOSIUM HIGHLIGHTS INCLUDE

WHO-ESCEO Symposium
“Assessment of Physical Performance in daily clinical practice”

Outcomes of an Expertsconsensus meeting organized by the European Society for Clinical and Economic
Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) under the auspices of the World Health Organization”

“Osteoporosis and sarcopenia :
Two diseases or one ?”

Lifetime course of muscle and bone wasting
C.Cooper, Southampton, UK
Role of nutrition and physical exercise in the prevention of bone and muscle wasting
R. Rizzoli, Geneva, Switzerland
What can we learn from osteoporosis to get a treatment against sarcopenia approved?
JY Reginster, Liège, Belgium

The ENRGISE pilot trial
to avert inflammation, mobility loss,
and frailty: early results

Stephen Kritchevsky
Wake Forest School of Medecine,
Winston-Salem, NC USA

 

PRELININARY PROGRAM

ONLINE ON NOVEMBER 2017

Call for abstracts: Symposium/Oral communication/Poster: Submission deadline: November 19, 2017

 

Responsive image